ARCHIVES

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

This article is from The Cancer Letter archive.

Vol. 25 No. 27 | July 9, 1999

Download PDF Visit The Full Archive

Related Articles

ACCC Manual Tells How To Set Up, Run Cancer Program

August 27, 1976

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

Clearinghouse Funds Two Carcinogens And A Threat To Humans

March 17, 1978

Monroe Wall, Co-Discoverer Of Taxol, Camptothecin, Dead At 85

July 12, 2002

In Brief: NCI Seeking Industry Support Again For Summer Program Congress Oks Smokeless Tobacco Bill

February 14, 1986

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010